UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023038
Receipt number R000026553
Scientific Title Brain imaging study on the relation between emotion and cognitive function
Date of disclosure of the study information 2016/07/07
Last modified on 2018/07/09 10:00:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Brain imaging study on the relation between emotion and cognitive function

Acronym

Brain imaging study on the relation between emotion and cognitive function

Scientific Title

Brain imaging study on the relation between emotion and cognitive function

Scientific Title:Acronym

Brain imaging study on the relation between emotion and cognitive function

Region

Japan


Condition

Condition

Dementia
Mild cognitive impairment

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to examine the relation between emotion and cognitive function by measuring the emotional tasks-induced brain activations using functional Magnetic Resonance Imaging (fMRI) and near-infrared spectroscopy (NIRS), and the levels of brain chemistry at the resting state using Magnetic Resonance Spectroscopy (MRS), in which we analyze the correlation between the brain imaging data and neuropsychological test scores, and compare these results between young and old subjects.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Brain activations (BOLD signal changes, hemoglobin concentration changes) and brain chemistry concentrations, such as GABA and Glx levels

Key secondary outcomes

Correlations between neuroimaging data (BOLD signal changes, hemoglobin concentration changes and brain chemical substances) and neuropsychological test scores


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

fMRI and NIRS measurements during the emotional task, MRS measurements during the resting state, and neuropsychological test

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1. Healthy participants aged 20 to 29 years (young), aged 65 to 74 years (elderly)
2. Individuals who have no history of psychiatric disease
3. Individuals who are right-handed
4. Individuals who are consent to participate in this study
5. Critetria for elderly subject: 1) Individuals with Mini-mental state examination scores over 26 at screening, 2) Individuals with Clinical dementia rating scale score 0, 3) Individuals whose ADL is normal without any memory problems

Key exclusion criteria

1. Individuals who have a history of traumatic brain injury with an unconsciousness lasting more than 5 minutes
2. Individuals who have a history of organic brain disease
3. Individuals who have a history of psychiatric disease
4. Individuals who have a history of substance dependence
5. Individuals who are taking central nervous system stimulants
6. Individuals who have a history of disorders of consciousness and/or seizure
7. Individuals who have a chronic headache
8. Individuals who have a risk for MRI scan
9. Criteria for elderly subject: 1) Individuals who have one or multiple following diagnosis: dementia (AD, FTLD, DLB), MCI, brain damage (cerebral infarction, brain hemorrhage, head trauma), Parkinsonism, Parkinson syndrome, corticobasal degeneration, 2) Individuals who have one or multiple following symptoms or disease: hearing difficulty, impaired vision, finger tremor, disease of cervical spine, cervical injury, neck pain

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasuomi Ouchi

Organization

Hamamatsu University School of Medicine

Division name

Department of Biofunctional Imaging

Zip code


Address

1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan

TEL

053-435-2466

Email

ouchi@hama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yumi Oboshi

Organization

Hamamatsu University School of Medicine

Division name

Department of Innovative Medical Photonics

Zip code


Address

1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan

TEL

053-435-2392

Homepage URL


Email

oboshi@hama-med.ac.jp


Sponsor or person

Institute

Preeminent Medical Photonics Education & Research Center, Hamamatsu University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Hamamatsu Medical Photonics Foundation

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

浜松PET診断センター(静岡県)、浜松医科大学


Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2016 Year 06 Month 20 Day

Date of IRB


Anticipated trial start date

2016 Year 08 Month 08 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 07 Month 06 Day

Last modified on

2018 Year 07 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026553


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name